CA2645265A1 - Water having anticancer action and method for producing the same - Google Patents
Water having anticancer action and method for producing the same Download PDFInfo
- Publication number
- CA2645265A1 CA2645265A1 CA002645265A CA2645265A CA2645265A1 CA 2645265 A1 CA2645265 A1 CA 2645265A1 CA 002645265 A CA002645265 A CA 002645265A CA 2645265 A CA2645265 A CA 2645265A CA 2645265 A1 CA2645265 A1 CA 2645265A1
- Authority
- CA
- Canada
- Prior art keywords
- water
- deleted
- tourmaline
- ion
- rock
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 246
- 230000001093 anti-cancer Effects 0.000 title claims description 32
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000011435 rock Substances 0.000 claims abstract description 96
- 239000011032 tourmaline Substances 0.000 claims abstract description 83
- 229940070527 tourmaline Drugs 0.000 claims abstract description 83
- 229910052613 tourmaline Inorganic materials 0.000 claims abstract description 83
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims abstract description 61
- 239000003456 ion exchange resin Substances 0.000 claims abstract description 61
- 229920003303 ion-exchange polymer Polymers 0.000 claims abstract description 61
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 50
- 235000012239 silicon dioxide Nutrition 0.000 claims abstract description 25
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 25
- 229910052751 metal Inorganic materials 0.000 claims description 45
- 239000002184 metal Substances 0.000 claims description 45
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 claims description 23
- 229910001415 sodium ion Inorganic materials 0.000 claims description 23
- 241000282414 Homo sapiens Species 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 15
- 229910052709 silver Inorganic materials 0.000 claims description 8
- 239000004332 silver Substances 0.000 claims description 8
- 239000004411 aluminium Substances 0.000 claims description 7
- 229910052782 aluminium Inorganic materials 0.000 claims description 7
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 7
- 229910010293 ceramic material Inorganic materials 0.000 claims description 7
- 239000010438 granite Substances 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 7
- 239000005332 obsidian Substances 0.000 claims description 7
- 229910001562 pearlite Inorganic materials 0.000 claims description 7
- 229910001220 stainless steel Inorganic materials 0.000 claims description 7
- 239000010935 stainless steel Substances 0.000 claims description 7
- 238000005342 ion exchange Methods 0.000 claims description 6
- 230000002411 adverse Effects 0.000 claims description 5
- 238000004090 dissolution Methods 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-O oxonium Chemical compound [OH3+] XLYOFNOQVPJJNP-UHFFFAOYSA-O 0.000 abstract description 37
- 150000002500 ions Chemical class 0.000 abstract description 36
- 239000008234 soft water Substances 0.000 abstract description 29
- 230000000694 effects Effects 0.000 abstract description 20
- 235000020188 drinking water Nutrition 0.000 abstract description 13
- 239000003651 drinking water Substances 0.000 abstract description 13
- -1 hydrogen ions Chemical class 0.000 abstract description 9
- 238000002347 injection Methods 0.000 abstract description 9
- 239000007924 injection Substances 0.000 abstract description 9
- 230000035622 drinking Effects 0.000 abstract description 6
- 239000001257 hydrogen Substances 0.000 abstract description 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 3
- 230000005907 cancer growth Effects 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 description 34
- 241000700159 Rattus Species 0.000 description 34
- 201000011510 cancer Diseases 0.000 description 32
- 210000004027 cell Anatomy 0.000 description 29
- 238000012360 testing method Methods 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 19
- 239000000460 chlorine Substances 0.000 description 15
- 239000000203 mixture Substances 0.000 description 14
- YZCKVEUIGOORGS-UHFFFAOYSA-N Hydrogen atom Chemical compound [H] YZCKVEUIGOORGS-UHFFFAOYSA-N 0.000 description 13
- 229940079593 drug Drugs 0.000 description 11
- 239000003814 drug Substances 0.000 description 11
- 230000000844 anti-bacterial effect Effects 0.000 description 10
- 230000000843 anti-fungal effect Effects 0.000 description 10
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 229910052801 chlorine Inorganic materials 0.000 description 8
- 229910021645 metal ion Inorganic materials 0.000 description 8
- 230000035755 proliferation Effects 0.000 description 8
- 238000013019 agitation Methods 0.000 description 7
- 229940121375 antifungal agent Drugs 0.000 description 7
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 6
- 230000037406 food intake Effects 0.000 description 6
- 238000010253 intravenous injection Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 230000004308 accommodation Effects 0.000 description 5
- 210000000170 cell membrane Anatomy 0.000 description 5
- 241000222518 Agaricus Species 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 238000002224 dissection Methods 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 201000004384 Alopecia Diseases 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 239000002246 antineoplastic agent Substances 0.000 description 3
- 229940041181 antineoplastic drug Drugs 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000024963 hair loss Diseases 0.000 description 3
- 230000003676 hair loss Effects 0.000 description 3
- 239000008233 hard water Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical group [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000002349 well water Substances 0.000 description 2
- 235000020681 well water Nutrition 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000001727 Tropicoporus linteus Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- JOPOVCBBYLSVDA-UHFFFAOYSA-N chromium(6+) Chemical compound [Cr+6] JOPOVCBBYLSVDA-UHFFFAOYSA-N 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000008239 natural water Substances 0.000 description 1
- GQPLMRYTRLFLPF-UHFFFAOYSA-N nitrous oxide Inorganic materials [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000006277 sulfonation reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000002341 toxic gas Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/005—Systems or processes based on supernatural or anthroposophic principles, cosmic or terrestrial radiation, geomancy or rhabdomancy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/42—Treatment of water, waste water, or sewage by ion-exchange
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/68—Treatment of water, waste water, or sewage by addition of specified substances, e.g. trace elements, for ameliorating potable water
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Environmental & Geological Engineering (AREA)
- Epidemiology (AREA)
- Water Supply & Treatment (AREA)
- Engineering & Computer Science (AREA)
- Hydrology & Water Resources (AREA)
- Geology (AREA)
- General Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Treatment Of Water By Ion Exchange (AREA)
- Physical Water Treatments (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006076790 | 2006-03-20 | ||
| JP2006-076790 | 2006-03-20 | ||
| JP2007015753A JP2007284420A (ja) | 2006-03-20 | 2007-01-26 | 抗癌性を有する水及びその水の製造方法 |
| JP2007-015753 | 2007-01-26 | ||
| PCT/JP2007/053348 WO2007108275A1 (ja) | 2006-03-20 | 2007-02-16 | 抗癌性を有する水及びその水の製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2645265A1 true CA2645265A1 (en) | 2007-09-27 |
Family
ID=38522311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002645265A Abandoned CA2645265A1 (en) | 2006-03-20 | 2007-02-16 | Water having anticancer action and method for producing the same |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20100233071A1 (OSRAM) |
| EP (1) | EP2005965A4 (OSRAM) |
| JP (1) | JP2007284420A (OSRAM) |
| KR (1) | KR20080111016A (OSRAM) |
| CN (1) | CN101405014B (OSRAM) |
| CA (1) | CA2645265A1 (OSRAM) |
| TW (1) | TW200800239A (OSRAM) |
| WO (1) | WO2007108275A1 (OSRAM) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014128257A (ja) * | 2012-12-30 | 2014-07-10 | Yasuyuki Katsura | 硬度が低く抵抗値の高い飲料水の精製 |
| WO2014149832A1 (en) | 2013-03-15 | 2014-09-25 | Optimedica Corporation | Microfemtotomy methods and systems |
| CN109912084A (zh) * | 2017-12-12 | 2019-06-21 | 北京慧博源生物科技有限公司 | 一种氢原子水机 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3904539A (en) * | 1973-01-02 | 1975-09-09 | Grefco | Insulation having a reduced thermal conductivity |
| CN1050679A (zh) * | 1990-11-07 | 1991-04-17 | 辽宁省阜新麦饭石开发公司鞍山分公司 | 元素营养液及其制取方法 |
| JP2889903B2 (ja) * | 1993-11-09 | 1999-05-10 | 利春 深井 | 浄化活性作用を有する水の製造方法及び製造装置 |
| JP4113964B2 (ja) * | 1998-12-16 | 2008-07-09 | 利春 深井 | 活性水素を有する水の製造方法及び製造装置 |
| JP2002210470A (ja) * | 2000-09-13 | 2002-07-30 | Yoshitaka Otomo | 水の酸化還元電位値をマイナスに還元精製するシステム及びその利用方法。 |
| JP3933403B2 (ja) * | 2001-02-28 | 2007-06-20 | 株式会社日本トリム | 電解還元水およびその製造方法 |
| JP2004230370A (ja) * | 2002-12-05 | 2004-08-19 | Wataru Murota | 還元水及びその製造方法 |
| JP2004330146A (ja) * | 2003-05-09 | 2004-11-25 | Nippon Torimu:Kk | 活性水素溶存水の製造方法、その製造方法により得られる活性水素溶存水および発癌抑制剤 |
| JP4718765B2 (ja) | 2003-05-30 | 2011-07-06 | 焼津水産化学工業株式会社 | 抗癌剤及びそれを含有する飲食品 |
-
2007
- 2007-01-26 JP JP2007015753A patent/JP2007284420A/ja active Pending
- 2007-02-16 US US12/225,373 patent/US20100233071A1/en not_active Abandoned
- 2007-02-16 CN CN2007800093697A patent/CN101405014B/zh not_active Expired - Fee Related
- 2007-02-16 EP EP07737337A patent/EP2005965A4/en not_active Withdrawn
- 2007-02-16 KR KR1020087022915A patent/KR20080111016A/ko not_active Ceased
- 2007-02-16 WO PCT/JP2007/053348 patent/WO2007108275A1/ja not_active Ceased
- 2007-02-16 CA CA002645265A patent/CA2645265A1/en not_active Abandoned
- 2007-03-07 TW TW096107844A patent/TW200800239A/zh unknown
-
2011
- 2011-04-19 US US13/089,616 patent/US20110195129A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN101405014A (zh) | 2009-04-08 |
| JP2007284420A (ja) | 2007-11-01 |
| EP2005965A4 (en) | 2009-06-10 |
| US20110195129A1 (en) | 2011-08-11 |
| US20100233071A1 (en) | 2010-09-16 |
| KR20080111016A (ko) | 2008-12-22 |
| WO2007108275A1 (ja) | 2007-09-27 |
| EP2005965A1 (en) | 2008-12-24 |
| CN101405014B (zh) | 2011-11-16 |
| TW200800239A (en) | 2008-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2175698C (en) | Method and apparatus for making water having purified and activated functions | |
| EP0889007A1 (en) | Reducing electrolytic water and method for preparing the same | |
| WO2003002466A1 (en) | Method for antioxidation and antioxidative functional water | |
| JP5358030B2 (ja) | 還元パウダー及びその製造方法 | |
| EP3260421A1 (en) | Composite mineralized ceramic material capable of producing active hydrogen healthcare water | |
| AU2016259438A1 (en) | Mitigation of animal and plant diseases using bioavailable minerals | |
| US20110195129A1 (en) | Water having anticancer activity and method for making the same | |
| EP0681841A1 (en) | $i(IN VIVO) FREE-RADICAL GENERATOR | |
| Tang et al. | Rational design of Au-Bi bimetallic nanozyme for NIR-II laser mediated multifunctional combined tumor therapy | |
| Li et al. | Transferrin-targeting pH-responsive and biodegradable mesoporous silica nanohybrid for nitric oxide-sensitized chemotherapy of cancer | |
| CN112791102A (zh) | 一种自增强化学动力学循环的肿瘤治疗材料 | |
| CN101323477A (zh) | 一种活化免疫养生水的制备方法 | |
| Chen et al. | Two-dimensional multifunctional nanosheets as radiosensitizers for chemodynamic/radio-therapy | |
| Hill et al. | Further studies of the action of a partially purified bacteriocin against a murine fibrosarcoma | |
| DE102016122768A1 (de) | Vorrichtung und Verfahren zum Erzeugen einer wasserstoffhaltigen Flüssigkeit | |
| Sommer et al. | pH and bicarbonate excretion in the rat parotid gland as a function of salivary rate | |
| JP2006096667A (ja) | 血糖値を低下させる水の製造方法 | |
| Wang et al. | Amifostine-loaded Prussian blue nanoparticles for simultaneous efficient radioprotection and deep decorporation of radiocesium | |
| CN110498516A (zh) | 具有净水并能够预防蓝藻水华的药物及其制备方法 | |
| CN115025118A (zh) | pH响应释放特性镓纳米药物与铂类化合物组合物在制备治疗耐药卵巢癌药物中的应用 | |
| Liu et al. | Macrophage-driven biohybrid microrobots orchestrating multi-enzyme cascades for hypoxic tumor targeted therapy | |
| Sun et al. | Discover Nano | |
| Meng et al. | PDGF receptor-β-targeted copper-zinc nanozyme interfered glycolysis and remodelled tumor microenvironment for enhanced cuproptosis of lung cancer | |
| Alam | A Systemacic Review of Vanadium and Derivates: Distribution of Coordination Complex and Application | |
| US20140212508A1 (en) | Copper/zinc superoxide dismutase (sod) formulation for the treatment of traumas including amyotropic lateral sclerosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20130218 |